Manulife (Manufacturers Life Insurance)’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.9K Sell
30,667
-17,544
-36% -$55.7K ﹤0.01% 2686
2025
Q4
$193K Sell
48,211
-6,059
-11% -$33.7K ﹤0.01% 2542
2025
Q3
$459K Sell
54,270
-4,566
-8% -$44.3K ﹤0.01% 2250
2025
Q2
$662K Sell
58,836
-801
-1% -$7.36K ﹤0.01% 2029
2025
Q1
$565K Buy
59,637
+1,746
+3% +$17.6K ﹤0.01% 2086
2024
Q4
$651K Sell
57,891
-7,063
-11% -$124K ﹤0.01% 2105
2024
Q3
$1.84M Sell
64,954
-2,545
-4% -$65.6K ﹤0.01% 1599
2024
Q2
$1.29M Buy
67,499
+4,572
+7% +$117K ﹤0.01% 1707
2024
Q1
$2.06M Buy
62,927
+8,833
+16% +$282K ﹤0.01% 1505
2023
Q4
$1.79M Sell
54,094
-913
-2% -$25.8K ﹤0.01% 1508
2023
Q3
$1.5M Buy
55,007
+10,896
+25% +$303K ﹤0.01% 1533
2023
Q2
$1.34M Buy
44,111
+10,562
+31% +$342K ﹤0.01% 1531
2023
Q1
$1.09M Buy
33,549
+293
+0.9% +$9.27K ﹤0.01% 1590
2022
Q4
$934K Buy
33,256
+402
+1% +$11.5K ﹤0.01% 1643
2022
Q3
$1.18M Sell
32,854
-552
-2% -$19.4K ﹤0.01% 1538
2022
Q2
$1.03M Buy
33,406
+411
+1% +$12K ﹤0.01% 1632
2022
Q1
$1.07M Sell
32,995
-7,084
-18% -$185K ﹤0.01% 1721
2021
Q4
$1.11K Sell
40,079
-221
-0.5% -$6.34K ﹤0.01% 1767
2021
Q3
$1.25M Sell
40,300
-4,285
-10% -$103K ﹤0.01% 1699
2021
Q2
$942K Buy
44,585
+1,411
+3% +$28.3K ﹤0.01% 2028
2021
Q1
$872K Sell
43,174
-2,471
-5% -$47K ﹤0.01% 1971
2020
Q4
$732K Buy
45,645
+1,441
+3% +$19K ﹤0.01% 2001
2020
Q3
$549K Sell
44,204
-1,723
-4% -$20.3K ﹤0.01% 1956
2020
Q2
$315K Sell
45,927
-2,402
-5% -$16.1K ﹤0.01% 2221
2020
Q1
$262K Buy
48,329
+3,041
+7% +$27.2K ﹤0.01% 2176
2019
Q4
$410K Sell
45,288
-477
-1% -$3.88K ﹤0.01% 2158
2019
Q3
$332K Hold
45,765
﹤0.01% 2261
2019
Q2
$364K Buy
45,765
+932
+2% +$11K ﹤0.01% 2242
2019
Q1
$564K Buy
44,833
+3,636
+9% +$57.6K ﹤0.01% 2015
2018
Q4
$822K Sell
41,197
-3,380
-8% -$78.2K ﹤0.01% 1674
2018
Q3
$1.27M Sell
44,577
-5,770
-11% -$138K ﹤0.01% 1661
2018
Q2
$1.06M Buy
50,347
+4,371
+10% +$82.7K ﹤0.01% 1847
2018
Q1
$656K Sell
45,976
-261
-0.6% -$3.74K ﹤0.01% 2132
2017
Q4
$569K Buy
46,237
+5,718
+14% +$80.6K ﹤0.01% 2230
2017
Q3
$722K Buy
40,519
+10,514
+35% +$217K ﹤0.01% 2015
2017
Q2
$760K Buy
30,005
+16,587
+124% +$399K ﹤0.01% 1989
2017
Q1
$299K Buy
13,418
+1,644
+14% +$31.6K ﹤0.01% 2547
2016
Q4
$174K Buy
11,774
+410
+4% +$8.08K ﹤0.01% 2891
2016
Q3
$280K Buy
11,364
+317
+3% +$7.41K ﹤0.01% 2509
2016
Q2
$212K Buy
11,047
+2,503
+29% +$34.4K ﹤0.01% 2663
2016
Q1
$91K Buy
8,544
+5,956
+230% +$61.5K ﹤0.01% 3089
2015
Q4
$32 Buy
2,588
+2,375
+1,115% +$35K ﹤0.01% 3341
2015
Q3
$3 Buy
+213
New +$4.16K ﹤0.01% 3768

Other funds holding EVH

Manulife (Manufacturers Life Insurance)'s EVH Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Evolent Health (EVH) stake by 36% in Q1 2026, selling an estimated $55.7K and leaving 30,667 shares worth $69.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2686.

Manulife (Manufacturers Life Insurance) first reported a position in EVH in Q3 2015 and has held it in 43 quarters since. The position peaked at $2.06M in Q1 2024. 192 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 30,667 shares of Evolent Health worth $69.9K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 17,544 Evolent Health shares in Q1 2026, an estimated $55.7K.
  • Evolent Health made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2686 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Evolent Health in Q3 2015 and has held it in 43 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Evolent Health position peaked at $2.06M in Q1 2024.
  • 192 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.